Peptide Laws in Germany
DE · Europe · 23 peptides tracked
Are Peptides Legal in Germany?
Germany follows the EU pharmaceutical framework, meaning unauthorized medicines can't be marketed or sold for human use. That said, 'research-use' peptides do circulate online and enforcement against individual buyers is low. The BfArM regulates medicines strictly, but personal possession of research chemicals isn't typically prosecuted. Semaglutide is available by prescription through the standard German healthcare system.
4
Legal11
Grey Area4
Prescription4
BannedCan You Buy Peptides in Germany?
4 peptide(s) are legal to buy in Germany, including GHK-Cu, NAD+, Glutathione, Vitamin B12. 4 peptide(s) require a valid prescription, including Tirzepatide, Semaglutide, HGH, Liraglutide. 11 peptide(s) fall into a legal grey area: Selank, MOTS-c, Semax, BPC-157, Retatrutide, and 6 more. These may be available for research purposes but their legality for personal use is ambiguous. 4 peptide(s) are banned: TB-500, Ipamorelin, CJC-1295, MK-677. Purchasing or possessing these is illegal.
Traveling to Germany with Peptides
When traveling to Germany with peptides, the legality depends on each peptide's classification. Do not bring banned substances (TB-500, Ipamorelin, CJC-1295, MK-677) — these could result in criminal penalties at customs. Prescription peptides (Tirzepatide, Semaglutide, HGH, Liraglutide) typically require documentation such as a prescription or doctor's letter when crossing borders. Enforcement in Germany is rated as "Strict." Always declare pharmaceutical products at customs and carry documentation of any prescriptions.
New to peptides? Start with the basics on peptide.camp →
Need to source peptides for Germany? Get verified wholesale quotes on peptide.broker →
Traveling to Germany with peptides? TSA tips, packing guides & the peptide travel case on peptide.travel →
Peptide Regulations in Germany
| Peptide | Status | Rx Required | Schedule | Detail | Source |
|---|---|---|---|---|---|
| Tirzepatide | Prescription | Yes | EMA Authorized (Rx) | EMA-authorized. Mounjaro. Prescription required. Unauthorised medicinal product under the Arzneimittelgesetz (AMG); placing on the market or unlicensed trade is punishable under AMG s.95. Criminal doping liability under the AntiDopG arises only for substances named in its annex, which is a closed list. | Official |
| Selank | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. Approved in Russia. Research-label available. Not on WADA prohibited list. Unauthorised medicinal product under the Arzneimittelgesetz (AMG); placing on the market or unlicensed trade is punishable under AMG s.95. Criminal doping liability under the AntiDopG arises only for substances named in its annex, which is a closed list. | Official |
| MOTS-c | Grey Area | No | Not Scheduled / Unauthorized | Research peptide. No EMA authorization. WADA banned. Minimal enforcement attention. Unauthorised medicinal product under the Arzneimittelgesetz (AMG); placing on the market or unlicensed trade is punishable under AMG s.95. Criminal doping liability under the AntiDopG arises only for substances named in its annex, which is a closed list. | Official |
| TB-500 | Banned | No | Antidopg Annex | Named in the AntiDopG annex, Section II (peptide hormones, growth factors and mimetics) as "Thymosin-beta-4 und seine Derivate". Acquiring, possessing or transporting a "nicht geringe Menge" for doping purposes is criminal under AntiDopG s.2(3); the DmMV 2023 annex sets that threshold at 100 mg. Penalties up to 3 years, or 1-10 years in aggravated cases (AntiDopG s.4). Separately an unauthorised medicinal product under the AMG. | Official |
| GHK-Cu | Legal | No | Cosmetic Ingredient | Legal cosmetic ingredient under EU Cosmetics Regulation 1223/2009. Topical forms sold freely. Injectable form unauthorized. Unauthorised medicinal product under the Arzneimittelgesetz (AMG); placing on the market or unlicensed trade is punishable under AMG s.95. Criminal doping liability under the AntiDopG arises only for substances named in its annex, which is a closed list. | Official |
| Ipamorelin | Banned | No | Antidopg Annex | Named explicitly in the AntiDopG annex, Section II. Acquiring, possessing or transporting a "nicht geringe Menge" for doping purposes is criminal under AntiDopG s.2(3). The DmMV 2023 annex sets the growth-hormone-secretagogue threshold at 150 mg. Penalties up to 3 years, or 1-10 years aggravated. Also an unauthorised medicinal product under the AMG. | Official |
| Semaglutide | Prescription | Yes | EMA Authorized (Rx) | EMA-authorized. Ozempic/Wegovy. Prescription required. Massive counterfeit/compounded market. EMA warned of 'sharp rise in illegal medicines'. Unauthorised medicinal product under the Arzneimittelgesetz (AMG); placing on the market or unlicensed trade is punishable under AMG s.95. Criminal doping liability under the AntiDopG arises only for substances named in its annex, which is a closed list. | Official |
| CJC-1295 | Banned | Yes | Antidopg Annex | Named explicitly in the AntiDopG annex, Section II. Acquiring, possessing or transporting a "nicht geringe Menge" for doping purposes is criminal under AntiDopG s.2(3). The DmMV 2023 annex sets the growth-hormone-secretagogue threshold at 150 mg. Penalties up to 3 years, or 1-10 years aggravated. Also an unauthorised medicinal product under the AMG. | Official |
| Semax | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. Approved in Russia. Research-label available. Not on WADA prohibited list. Unauthorised medicinal product under the Arzneimittelgesetz (AMG); placing on the market or unlicensed trade is punishable under AMG s.95. Criminal doping liability under the AntiDopG arises only for substances named in its annex, which is a closed list. | Official |
| BPC-157 | Grey Area | No | Not Scheduled / Unauthorized | Unauthorised medicinal product under the Arzneimittelgesetz (AMG). Placing on the market or unlicensed trade is punishable under AMG s.95 (up to 3 years; 1-10 years in aggravated cases). NOT listed in the AntiDopG annex, which is a closed list — so the doping-specific criminal offences in AntiDopG s.2 do not apply to BPC-157. Direct mail order from outside the EU is not permitted under AMG s.73. | Official |
| NAD+ | Legal | No | Supplement / Novel Food | Supplements (NMN/NR) widely sold. IV infusions at clinics. NMN awaiting EFSA novel food assessment (Uthever 2025). Unauthorised medicinal product under the Arzneimittelgesetz (AMG); placing on the market or unlicensed trade is punishable under AMG s.95. Criminal doping liability under the AntiDopG arises only for substances named in its annex, which is a closed list. | Official |
| Retatrutide | Grey Area | No | Investigational | Phase 3 clinical trials. No EMA approval. Any online sales illegal. FDA warned against compounded versions. Unauthorised medicinal product under the Arzneimittelgesetz (AMG); placing on the market or unlicensed trade is punishable under AMG s.95. Criminal doping liability under the AntiDopG arises only for substances named in its annex, which is a closed list. | Official |
| AOD-9604 | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GH fragment. Research-label available. Unauthorised medicinal product under the Arzneimittelgesetz (AMG); placing on the market or unlicensed trade is punishable under AMG s.95. Criminal doping liability under the AntiDopG arises only for substances named in its annex, which is a closed list. | Official |
| Glutathione | Legal | No | Supplement | Oral form: Food supplement under EU Directive 2002/46/EC. Reduced L-glutathione has history of consumption pre-1997 (not Novel Food). S-Acetyl-L-Glutathione pending Novel Food authorization. | Unsourced |
| DSIP | Grey Area | No | Not Scheduled / Unauthorized | Unauthorized medicinal product under AMG. Not listed in AntiDopG Annexes. Import triggers prosecution under pharmaceutical law. | Unsourced |
| Epithalon | Grey Area | No | Not Scheduled / Unauthorized | Unauthorized medicinal product under AMG. Not in AntiDopG Annexes. | Unsourced |
| KPV | Grey Area | No | Not Scheduled / Unauthorized | Unauthorized medicinal product under AMG. | Unsourced |
| HGH | Prescription | Yes | EMA Authorized (Rx) | EMA-authorized. Multiple products: Genotropin, Omnitrope, Norditropin. Prescription-only (verschreibungspflichtig). Not covered by public insurance for anti-aging use. | Unsourced |
| Liraglutide | Prescription | Yes | EMA Authorized (Rx) | EMA-authorized. Victoza (diabetes) and Saxenda (weight management) approved. Prescription-only. GLP-1 for weight loss generally not covered by GKV public insurance. | Unsourced |
| Melanotan II | Grey Area | No | Not Scheduled / Unauthorized | Unauthorized medicinal product under AMG. Referenced in enforcement discussions. EU Parliament raised formal question about Melanotan abuse. | Unsourced |
| Vitamin B12 | Legal | No | Supplement | Oral: Food supplement under EU Directive 2002/46/EC. Injectable: Prescription medicinal product (verschreibungspflichtig). | Unsourced |
| PT-141 | Grey Area | No | Not Scheduled / Unauthorized | Not EMA-authorized. Unauthorized medicinal product under AMG. | Unsourced |
| MK-677 | Banned | No | Antidopg Annex | Named explicitly in the AntiDopG annex, Section II. Acquiring, possessing or transporting a "nicht geringe Menge" for doping purposes is criminal under AntiDopG s.2(3). The DmMV 2023 annex sets the growth-hormone-secretagogue threshold at 150 mg. Penalties up to 3 years, or 1-10 years aggravated. Also an unauthorised medicinal product under the AMG. | Official |
About the sources on this page
Entries marked Official cite a government regulator, legislation or an official gazette. Some entries currently carry no source at all.
We show these entries rather than hiding them, but they should not be relied on. Nothing on this site is legal advice. Verify against the national regulator before acting, and if you can point us at a better source please submit an update.
Data is researcher-verified but not legal advice. Always consult local regulations before purchasing, importing, or traveling with peptides. Last verified: 2026-02-28.